BRIEF-Orexigen Therapeutics Q3 loss per share $1.35
November 13, 2017 at 16:03 PM EST
* Orexigen Therapeutics announces third quarter 2017 financial results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.